Shiqin Zhang

Also affiliated with University of Kansas Medical Center, Guangzhou Electronic Technology (China)

Biochemistry, Genetics and Molecular BiologyEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD”.

Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD

Kidney360(2020)10.34067/kid.0003942020

N/A

0.817DataRank · unranked

22 citations

Shiqin Zhang, Cassandra Johnson, Raymond E. West, Alexander J. Prokopienko, Jonathan D. Mahnken +12 more

Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease

Kidney International Reports(2021)10.1016/j.ekir.2021.01.004

N/A

0DataRank · unranked

17 citations

Pengcheng Lu, Jonathan D. Mahnken, Jason R. Stubbs, Shiqin Zhang, Darren P. Wallace +11 more